Ureteral Reimplantation for Vesicoureteral Reflux (VUR)
Treatment for Urogenital Congenital Anomalies
Effectiveness
96%
Safety Score
65%
Clinical Trials
400
Participants
25K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate anatomical correction, reflux resolution confirmed post-op
Treatment Duration
Single surgery, follow-up for several years
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$3,500
Side Effect Mgmt:$1,000
Total Annual:$18,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$35,000/QALY
QALYs Gained
1.8
Outcome-Based Costs
Cost per Responder
$18,750
Cost per Remission
$18,750
Comparison vs Continuous Antibiotic Prophylaxis + Watchful Waiting
Cost Difference
$0/year
Same cost
QALY Difference
+1.80 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Ureteral Reimplantation for Vesicoureteral Reflux (VUR) Outcomes
for Urogenital Congenital Anomalies
Efficacy Outcomes
Overall Effectiveness
+96%
Response Rate
+96%
Remission Rate
+96%
Common Side Effects
Bladder spasm/pain
+20%
Urinary tract infection (post-op)
+8%
Temporary ureteral obstruction
+3%
Persistent VUR
+4%
Urinary retention
+3%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov